.png)
Andrii Yalanskyi/iStock via Getty Images
The Health and Human Services (HHS) department on Tuesday said under President Donald Trump’s most-favored-nation drug pricing policy, it will require drugmakers to lower prices of branded medicines to the level of those in OECD countries.
The announcement comes a
English (US) ·